Probiotic shows promise for fatty liver in early trial
NCT ID NCT07378280
First seen Feb 01, 2026 · Last updated Apr 30, 2026 · Updated 16 times
Summary
This study tested whether a probiotic called L. lactis CKDB001 can improve liver health in people with nonalcoholic fatty liver disease (NAFLD). About 95 adults with mildly elevated liver enzymes took the probiotic or a placebo for 12 weeks. The main goal was to see if the probiotic lowered liver enzyme levels, which are markers of liver stress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon-do, 24210, South Korea
Conditions
Explore the condition pages connected to this study.